ASML at a Crossroads: Record Highs Meet Political Peril as Q2 Earnings Loom

ASML shares surge 63% YTD on AI demand, but July 15 Q2 results and potential US export controls on China service operations threaten the rally.

The Dutch lithography giant is riding a wave of optimism that has pushed its shares to near-record levels, yet a gathering storm over its lucrative China service business threatens to puncture the rally. Investors will get their clearest reading yet on July 15, when ASML publishes second-quarter results that could determine whether the stock’s 63% year-to-date surge has further to run—or if a correction is overdue.

Shares in the chipmaking equipment monopolist added another 3.34% on Friday, touching €1,601.80 and leaving the 52-week high of €1,748 within striking distance. The gains have been fuelled by a potent mix of relentless AI hardware demand and fresh analyst upgrades. Jefferies raised its price target to €1,560 on Friday, while UBS reiterated ASML as its top pick in European technology. For the second quarter, Jefferies forecasts revenue of €8.79 billion and a gross margin of 52%—numbers that, if confirmed, would be solid but hardly a catalyst.

The real prize lies in the full-year guidance. ASML’s management previously outlined a sales ceiling of €40 billion for 2025, but Jefferies now expects that to be revised sharply higher, possibly to a range of up to €42 billion. Such a move would validate the market’s lofty valuation and reinforce the narrative of a company benefiting from an unprecedented chipmaking capacity buildout across the US, South Korea, and Japan. CEO Christophe Fouquet has described the global semiconductor market as persistently strained, with demand from artificial intelligence, satellite technology, and robotics all competing for scarce production capacity.

Yet the bullish thesis is being tested by mounting political pressure on ASML’s service operations in China. The US government is reportedly considering expanding export controls to cover the maintenance and repair of existing Deep Ultraviolet (DUV) lithography systems already installed in Chinese factories. Those service contracts have been a reliable cash cow for ASML, generating high-margin recurring revenue that helps fund the costly ramp-up of new High-NA EUV tools. A ban on servicing Chinese machines would not only threaten a profitable income stream but could also trigger breach-of-contract lawsuits from Chinese clients. Fouquet has warned that severe sanctions could backfire by accelerating China’s domestic chipmaking efforts, creating long-term competitors in the DUV segment.

The bull case, however, rests on ASML’s unassailable technological monopoly and the sheer weight of order backlogs. The company is the sole supplier of the extreme ultraviolet (EUV) systems needed for cutting-edge chip production, and the newer High-NA models are setting industry standards that allow customers to consolidate multiple fabrication steps. If a Chinese service ban materialises, the argument goes, Western and Asian chipmakers can immediately absorb the machines originally destined for China, because demand is so insatiable. Jefferies meanwhile projects that ASML will deliver around 90 of its next-generation Low-NA EUV systems in 2027 alone, a volume that underscores why analysts see multiyear growth ahead.

The stock’s technical picture suggests a market holding its breath. After hitting a record high in late June, the share price has consolidated, with the relative strength index (RSI) settling near 54—a neutral reading that leaves room for movement in either direction. The July 15 report will be a litmus test for the entire narrative. Investors will zero in on three items: the updated outlook for service revenue in the second half of the year, the status of Chinese service licences, and progress on certifying and shipping the new High-NA systems.

If ASML confirms robust demand outside China and keeps its guidance intact, the uptrend is likely to resume. But any sign that political headwinds are crimping service income could trigger an immediate sell-off, as the market re-evaluates the risk premium baked into ASML’s elevated multiple. The coming weeks will tell whether the company’s two-front battle—raging AI demand on one side, encroaching geopolitics on the other—ends in a breakout or a breakdown.